Akums Pharma’s IPO to open on July 30, 2024
Price Band fixed at ₹ 646 to ₹ 679 per equity share of face value of ₹ 2 each
Author
NewAmsterdam’s obicetrapib holds potential to become first CETP inhibitor to advance to clinical…
According to GlobalData, NewAmsterdam’s obicetrapib is expected to be the most promising agent to launch in the dyslipidemia…
Eisai and EcoNaviSta collaborate to build a dementia ecosystem
Eisai and EcoNaviSta will conduct joint research aimed at the early detection of MCI and dementia even in healthy seniors, and…
The politics of health: how elections will impact on life sciences
Ivor Campbell, Chief Executive, Snedden Campbell, a specialist recruitment consultant for the medical technology industry…
DP World receives the AEO-LO program accreditation administered by CBIC
The certification, under the aegis of the WCO SAFE Framework of Standards, is awarded to companies whose operations strengthen…
Pfizer’s gene therapy for Haemophilia A receives positive topline results from Phase 3 Study
Giroctocogene fitelparvovec study meets primary and key secondary objectives of superiority compared to prophylaxis
RCC diagnosed incident cases to reach 230,000 in 8MM by 2033: GlobalData
According to GlobalData epidemiologists, there were 19.90 per cent of stage III diagnosed incident cases of RCC and 17.90 per cent…
Budget 2024-25 prioritises R&D, education and business for MSMEs
Industry stakeholders appreciate the efforts made towards increasing employment, skill-building and implementation of various…
Alembic gains USFDA final approval for Fluphenazine Hydrochloride Tablets USP, 1 mg, 2.5 mg, 5 mg,…
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Prolixin Tablets, 1 mg, 2.5 mg, 5mg,…
Novo Nordisk’s Wegovy gets MHRA nod for use to lower heart risks
Semaglutide is the first weight loss drug approved in the UK as a preventative treatment for those with established cardiovascular…